Downloads: 13
Review Papers | Health and Medical Sciences | Volume 11 Issue 4, April 2022 | Pages: 1275 - 1279 | India
Prevalence of Drug-Induced Hypothyroidism in Multi-Drug Resistant Tuberculosis Patients
Abstract: Tuberculosis (TB) existed for long years and still remains a major global health problem in developing countries. It is airborne and caused by Mycobacterium tuberculosis complex. Multi-drug resistant TB (MDR-TB) is caused by drugs used to treat tuberculosis which include isoniazid and rifampicin. This has emerged as a significant threat to TB control in India, with more than 62000 new cases annually. The prevalence of drug-induced hypothyroidism in multi drug-resistant tuberculosis patients is always a dilemma. This review focuses on the detailed data on prevalence of drug-induced Hypothyroidism in MDR TB patients.
Keywords: Drug-induced Hypothyroidism, Multi-Drug Resistant Tuberculosis, Prevalence
How to Cite?: Dr. Noushadali SK, Dr. Kas Noorulla, Dr. Mehnaz Talat, Dr. Shabana Begum SK, "Prevalence of Drug-Induced Hypothyroidism in Multi-Drug Resistant Tuberculosis Patients", Volume 11 Issue 4, April 2022, International Journal of Science and Research (IJSR), Pages: 1275-1279, https://www.ijsr.net/getabstract.php?paperid=MR22428130435, DOI: https://dx.doi.org/10.21275/MR22428130435